MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06082namaa22004331i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250223033218.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
231211s2022 ua a|||frm||| 000 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-GICUC |
| Language of cataloging |
eng |
| Transcribing agency |
EG-GICUC |
| Modifying agency |
EG-GICUC |
| Description conventions |
rda |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| Language code of summary or abstract |
eng |
| -- |
ara |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
Deposit |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
610.73678 |
| Edition number |
21 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
610.73678 |
| Edition number |
21 |
| 097 ## - Thesis Degree |
|---|
| Thesis Level |
M.Sc |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| Classification number |
Cai01.17.02.M.Sc.2022Fa.H |
| 100 0# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Fatma Forig Abd El-Qawi Abd El-Samad Oun, |
| Relator term |
preparation. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Health Problems among Levonorgestrel-Releasing Intrauterine System (Mirena) Users / |
| Statement of responsibility, etc. |
by Fatma Forig Abd El-Qawi Abd El-Samad Oun ; advisors Dr. Reda Mohmad Nabil Aboushady, Dr. Omaima Abdel-Fatah Idris, Dr. Walaa Mahmoud Abdel-Rahman. |
| 246 15 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
المشاكل الصحية بين مستخدمى اللولب الهرمونى (مارينا) |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
2023. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
74 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
30 cm. + |
| Accompanying material |
CD. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
Unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Thesis (Ph.D)-Cairo University, 2022. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Bibliography: pages 67-74. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Despite their known efficacy, recent studies have found that there is adverse health<br/>problem accompanied with Mirena as follows; anxious‐depressive disorders, sexual<br/>disorders, weight gain, and pain (gastrointestinal, musculoskeletal). Therefore, the current<br/>study aims to assess health problems among Levonorgestrel-releasing intrauterine system<br/>(Mirena) users. A descriptive design was utilized in the current study. This study was<br/>conducted at gynecological clinic in Rofayda Obstetrics and Gynecology private Hospital,<br/>el-sheik Zaid, El Giza Sector-Egypt. A purposive sample of 50 women using<br/>Levonorgestrel-releasing intrauterine (Mirena) system for at least six months. Two tools<br/>were used for data collection; 1) Health problems assessment tool and 2) Satisfaction level<br/>among Mirena users tool. Results: The mean age among the study sample was 35.56 ± 6.42<br/>years. The common health problems among the study sample were physical problems 24%<br/>in form of headache, 40% had weight gain, dermatological problem including 34% acne<br/>and 22% of the study sample had menstrual disturbance. Regarding psychological<br/>disturbance, 32% had depression, 42% had mood swings, Regarding gynecological<br/>problems, 22% had a vaginal infection. As well as, 8% had a decrease in libido.<br/>Conclusion: Mirena is a promising and effective option for contraceptive and noncontraceptive<br/>methods. It is associated with health problems, as reported by Mirena users.<br/>Recommendations: Organized educational guidelines about uses, complaints, and health<br/>problems towards Mirena as; lectures, handouts, and videos should be designed and<br/>become accessible to all women in the outpatient clinics. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
الصحة الإنجابية جزء أساسى من حياة الإنسان , ووسائل منع الحمل ضرورية للمرأة وتعتبر جزءا من حقوق<br/>الإنسان الأساسية وكذلك تعزز الدور الحيوى للمرأة في جميع أنحاء العالم . كان أول استخدام لحبوب منع الحمل التى<br/>تؤخذ عن طريق الفم في عام 0691 ثم توالي تطوير وسائل منع الحمل لإعطاء المرأة المزيد من الخيارات والتحكم فيما<br/>يخص الصحة الإنجابية من خلال استخدام وسائل منع الحمل المتطورة الحديثة والفعالة .تم استخدام التكنولوجيا لتوفير<br/>مجموعة متنوعة من وسائل منع الحمل وتوفيرها للسيدات والتي تمكنهم من الحصول علي خيارات مناسبة وعديدة يسهل<br/>الوصول إليها وفي متناول الجميع في سن الإنجاب . موانع الحمل الهرمونية المؤقتة وطويلة الأجل منها اللولب الهرمونى<br/>حيث أنه عالى الفعالية بين مستخدميه, ولذلك لما له من مشاكل صحية وزيارات متابعة ووصفة تكرار أقل بالمقارنة مع<br/>وسائل منع الحمل الأخرى.<br/>اللولب الهرمونى )ميرينا( هو وسيلة فعالة لمنع الحمل , وله نتائج فعالة لعلاج النزيف الرحمى. يعتبر منع الحمل<br/>هو استخدام معتمد لوسائل منع الحمل ويستخدم في جميع أنحاء العالم وينتشر بصورة كبيرة حيث يبلغ استخدام موانع<br/>الحمل كل عام ) 92.6 ٪(. ومما يميزه أنه يمكن إيقاف تأثيره وعودة الخصوبة في المعدل الطبيعى مما يجعله وسيلة مناسبة<br/>للكثير من السيدات.استخدام اللولب الهرمونى )ميرينا ( لا يمنع عملية التبويض , ولكنه يقلل من سمك بطانة الرحم ,كذلك<br/>يجعل مخاط عنق الرحم أكثر سمكًا مما يمنع وصول الحيوانات المنوية إلى الرحم وقناتى فالوب مما يعيق عملية تخصيب<br/>البويضة . لا يحمي اللولب الهرمونى من عدوى الحوض والأمراض المنقولة جنسياً. علاوة على ذلك , قد يكون فعالًا في |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
|---|
| Additional physical form available note |
Issues also as CD. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
Text in English and abstract in Arabic & English. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Gynecologic nursing. |
| 653 #0 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Health problems |
| -- |
levonorgestrel-releasing |
| -- |
intrauterine system (Mirena) users |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Reda Mohmad Nabil Aboushady, |
| Relator term |
thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Omaima Abdel-Fatah Idris, |
| Relator term |
thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Walaa Mahmoud Abdel-Rahman, |
| Relator term |
thesis advisor. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a> |
| 900 ## - EQUIVALENCE OR CROSS-REFERENCE-PERSONAL NAME [LOCAL, CANADA] |
|---|
| Numeration |
01-01-2023 |
| Titles and other words associated with a name |
Reda Mohmad Nabil Aboushady |
| -- |
Omaima Abdel-Fatah Idris |
| -- |
Walaa Mahmoud Abdel-Rahman |
| Universities |
Cairo University |
| Faculties |
Faculty of Nursing |
| Divisons |
Department of Maternal and Newborn Health Nursing |
| 905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
|---|
| Cataloger |
Asmaa |
| Reviser |
Hanan |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Thesis |
| Edition |
21 |
| Suppress in OPAC |
No |
